Skip to main content
Top
Published in: World Journal of Pediatrics 3/2018

01-06-2018 | Original Article

Introducing an antibiotic stewardship program in a pediatric center in China

Authors: Zhi-Gang Zhang, Fei Chen, Jian-Zhong Chen

Published in: World Journal of Pediatrics | Issue 3/2018

Login to get access

Abstract

Background

This study aimed to investigate the effect of antibiotic stewardship programs (ASP) on reducing antimicrobial resistance rate, antibiotics consumption and multi-drug resistance bacterial infections in the pediatric patients.

Methods

This study was carried out in the Pediatric Center of a tertiary hospital of Shandong Province, China. The study duration was separated into two periods according to introduction of ASP (began from April 2011). Before intervention: from April 2009 to March 2011; after intervention: from April 2012 to March 2014. The consumption of antibiotics, defined daily dose (DDD), isolation of multidrug-resistant organisms (MDRO) and resistance rate of antibiotics were analyzed and compared between the two study periods.

Results

Total antibiotics consumption (DDDs) reduced from 56,725 in 2011 to 31,380 in 2014; antibiotic use density (AUD) reduced from 93.8 to 43.5; mean (± SD) antibiotic costs per patient (per quarter) decreased from 637 (± 29) RMB to 462 (± 49) RMB; and the mean total drug consumption (g)/DDD (DDDs) for inpatients decreased from 90.4 (± 3.3) to 56.4 (± 9.5). Multidrug-resistant microorganisms isolation reduced significantly from 463 (20.0) to 216 (6.9%). Resistance rate of general spectrum antibiotics reduced remarkably after intervention. The proportion of patients colonized or infected with Carbapenems-resistant Acinetobacter baumannii was correlated with DDDs of carbapenem.

Conclusions

Implementation of ASP leads to reduced medical expense, decrease of improper and abuse of antibiotics, and reduced antibiotics resistance rate and MDRO isolation. Continuous efforts to improve antibiotic use are required.
Literature
3.
go back to reference Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. Cochrane Database Syst Rev. 2013;(4):CD003543. Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. Cochrane Database Syst Rev. 2013;(4):CD003543.
4.
go back to reference Malani AN, Richards PG, Kapila S, Otto MH, Czerwinski J, Singal B. Clinical and economic outcomes from a community hospital’s antimicrobial stewardship program. Am J Infect Control. 2013;41:145–8.CrossRefPubMed Malani AN, Richards PG, Kapila S, Otto MH, Czerwinski J, Singal B. Clinical and economic outcomes from a community hospital’s antimicrobial stewardship program. Am J Infect Control. 2013;41:145–8.CrossRefPubMed
5.
go back to reference Zhang R, Eggleston K, Rotimi V, Zeckhauser RJ. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health. 2006;2:6.CrossRefPubMedPubMedCentral Zhang R, Eggleston K, Rotimi V, Zeckhauser RJ. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health. 2006;2:6.CrossRefPubMedPubMedCentral
6.
go back to reference Sun T. The use of antibiotics and bacterial resistance. Chin J Clin Pharmacol. 2014;30:151–5. Sun T. The use of antibiotics and bacterial resistance. Chin J Clin Pharmacol. 2014;30:151–5.
7.
go back to reference Hu FP, Zhu DM, Wang F, Jiang XF, Xu YC, Zhang XJ, et al. CHINET 2014 surveillance of bacterial resistance in China. Chin J Infect Chemother. 2015;15:402–10. Hu FP, Zhu DM, Wang F, Jiang XF, Xu YC, Zhang XJ, et al. CHINET 2014 surveillance of bacterial resistance in China. Chin J Infect Chemother. 2015;15:402–10.
8.
go back to reference Levy SB. The 2000 Garrod lecture.Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother. 2002;49:25–30.CrossRefPubMed Levy SB. The 2000 Garrod lecture.Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother. 2002;49:25–30.CrossRefPubMed
9.
go back to reference Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol. 1997;18:275–91.CrossRefPubMed Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol. 1997;18:275–91.CrossRefPubMed
10.
go back to reference Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microb Infect. 2012;18:268–81.CrossRef Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microb Infect. 2012;18:268–81.CrossRef
11.
go back to reference Oucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. Bad bugs, no drugs: no ESKAPE! an update from the infectious diseases society of America. Clin Infect Dis. 2009;48:1–12.CrossRef Oucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. Bad bugs, no drugs: no ESKAPE! an update from the infectious diseases society of America. Clin Infect Dis. 2009;48:1–12.CrossRef
12.
go back to reference Heddini A, Cars O, Qiang S, Tomson G. Antibiotic resistance in China–a major future challenge. Lancet. 2009;373:30.CrossRefPubMed Heddini A, Cars O, Qiang S, Tomson G. Antibiotic resistance in China–a major future challenge. Lancet. 2009;373:30.CrossRefPubMed
13.
go back to reference Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010;51:189–94.CrossRefPubMed Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010;51:189–94.CrossRefPubMed
14.
go back to reference Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25:682–707.CrossRefPubMedPubMedCentral Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25:682–707.CrossRefPubMedPubMedCentral
15.
go back to reference Nordmann P, Dortet L, Poirel L. Carbapenems resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18:263–72.CrossRefPubMed Nordmann P, Dortet L, Poirel L. Carbapenems resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18:263–72.CrossRefPubMed
16.
go back to reference Yang YH, Fu SG, Peng H, Shen AD, Yue SJ, Go YF, Yuan L, Jiang ZF. Abuse of antibiotics in China and its potential interference in determining the etiology of pediatric bacterial diseases. Pediatr Infect Dis J. 1993;12:986–8.CrossRefPubMed Yang YH, Fu SG, Peng H, Shen AD, Yue SJ, Go YF, Yuan L, Jiang ZF. Abuse of antibiotics in China and its potential interference in determining the etiology of pediatric bacterial diseases. Pediatr Infect Dis J. 1993;12:986–8.CrossRefPubMed
17.
go back to reference Zhang W, Shen X, Bergman U, Wang Y, Chen Y, Huang M, et al. Drug utilisation 90% (DU90%) profiles of antibiotics in five Chinese children’s hospitals (2002–2006). Int J Antimicrob Agents. 2008;32:250–5.CrossRefPubMed Zhang W, Shen X, Bergman U, Wang Y, Chen Y, Huang M, et al. Drug utilisation 90% (DU90%) profiles of antibiotics in five Chinese children’s hospitals (2002–2006). Int J Antimicrob Agents. 2008;32:250–5.CrossRefPubMed
18.
go back to reference Zhang W, Shen X, Wang Y, Chen Y, Huang M, Zeng Q, et al. Antibiotic use in five children’s hospitals during 2002-2006: the impact of antibiotic guidelines issued by the Chinese Ministry of Health. Pharmacoepidemiol Drug Saf. 2008;17:306–11.CrossRefPubMed Zhang W, Shen X, Wang Y, Chen Y, Huang M, Zeng Q, et al. Antibiotic use in five children’s hospitals during 2002-2006: the impact of antibiotic guidelines issued by the Chinese Ministry of Health. Pharmacoepidemiol Drug Saf. 2008;17:306–11.CrossRefPubMed
19.
go back to reference Zhang W, Shen X, Wang Y, Chen Y, Huang M, Zeng Q, et al. Outpatient antibiotic use and assessment of antibiotic guidelines in Chinese children’s hospitals. Eur J Clin Pharmacol. 2008;64:821–8.CrossRefPubMed Zhang W, Shen X, Wang Y, Chen Y, Huang M, Zeng Q, et al. Outpatient antibiotic use and assessment of antibiotic guidelines in Chinese children’s hospitals. Eur J Clin Pharmacol. 2008;64:821–8.CrossRefPubMed
20.
go back to reference Ma X, Xie J, Yang Y, Guo F, Gao Z, Shao H. Antimicrobial stewardship of Chinese ministry of health reduces multidrug-resistant organism isolates in critically ill patients: a pre-post study from a single center. BMC Infect Dis. 2016;16:704.CrossRefPubMedPubMedCentral Ma X, Xie J, Yang Y, Guo F, Gao Z, Shao H. Antimicrobial stewardship of Chinese ministry of health reduces multidrug-resistant organism isolates in critically ill patients: a pre-post study from a single center. BMC Infect Dis. 2016;16:704.CrossRefPubMedPubMedCentral
21.
go back to reference Bhalla N, Hussein N, Atari M, Fakhri RM, Lepora C, Walsh N, et al. Introducing an antibiotic stewardship program in a humanitarian surgical hospital. Am J Infect Control. 2016;44:1381–4.CrossRefPubMed Bhalla N, Hussein N, Atari M, Fakhri RM, Lepora C, Walsh N, et al. Introducing an antibiotic stewardship program in a humanitarian surgical hospital. Am J Infect Control. 2016;44:1381–4.CrossRefPubMed
22.
go back to reference Wu CT, Chen CL, Lee HY, Chang CJ, Liu PY, Li CY, et al. Decreased antimicrobial resistance and defined daily doses after implementation of a clinical culture-guided antimicrobial stewardship program in a local hospital. J Microbiol Immunol Infect. 2015;50:846–56.CrossRefPubMed Wu CT, Chen CL, Lee HY, Chang CJ, Liu PY, Li CY, et al. Decreased antimicrobial resistance and defined daily doses after implementation of a clinical culture-guided antimicrobial stewardship program in a local hospital. J Microbiol Immunol Infect. 2015;50:846–56.CrossRefPubMed
23.
go back to reference Ogutlu A, Guclu E, Karabay O, Utku AC, Tuna N, Yahyaoglu M. Effects of carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients. Ann Clin Microbiol Antimicrob. 2014;13:7.CrossRefPubMedPubMedCentral Ogutlu A, Guclu E, Karabay O, Utku AC, Tuna N, Yahyaoglu M. Effects of carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients. Ann Clin Microbiol Antimicrob. 2014;13:7.CrossRefPubMedPubMedCentral
24.
go back to reference Sistanizad M, Kouchek M, Miri M, Goharani R, Solouki M, Ayazkhoo L, Foroumand M, Mokhtari M. Carbapenem restriction and its effect on bacterial resistance in an intensive care unit of a teaching hospital. Iran J Pharm Res. 2013;12:503–9.PubMedPubMedCentral Sistanizad M, Kouchek M, Miri M, Goharani R, Solouki M, Ayazkhoo L, Foroumand M, Mokhtari M. Carbapenem restriction and its effect on bacterial resistance in an intensive care unit of a teaching hospital. Iran J Pharm Res. 2013;12:503–9.PubMedPubMedCentral
25.
go back to reference Maltezou HC, Kontopidou F, Katerelos P, Daikos G, Roilides E, Theodoridou M. Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children. Pediatr Infect Dis J. 2013;32:e151–4.CrossRefPubMed Maltezou HC, Kontopidou F, Katerelos P, Daikos G, Roilides E, Theodoridou M. Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children. Pediatr Infect Dis J. 2013;32:e151–4.CrossRefPubMed
26.
go back to reference Muraki Y, Kitamura M, Maeda Y, Kitahara T, Mori T, Ikeue H, et al. Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010. Infection. 2013;41:415–23.CrossRefPubMed Muraki Y, Kitamura M, Maeda Y, Kitahara T, Mori T, Ikeue H, et al. Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010. Infection. 2013;41:415–23.CrossRefPubMed
Metadata
Title
Introducing an antibiotic stewardship program in a pediatric center in China
Authors
Zhi-Gang Zhang
Fei Chen
Jian-Zhong Chen
Publication date
01-06-2018
Publisher
Childrens Hospital, Zhejiang University School of Medicine
Published in
World Journal of Pediatrics / Issue 3/2018
Print ISSN: 1708-8569
Electronic ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-018-0133-y

Other articles of this Issue 3/2018

World Journal of Pediatrics 3/2018 Go to the issue